Generare is a French biotech startup that develops a drug discovery platform to identify and clone natural molecules from microorganisms for new antibiotics and anticancer drugs.

Parse Biosciences is a company that develops and commercializes scalable single-cell sequencing technologies for use in over 1,000 labs globally, aiming to expand its product range and market presence with its recent $50 million funding.